Table 4. Univariate analysis of the baseline characteristics and HRSV genotypes of hospitalized and non-hospitalized patients.
| No. (%) of HRSV cases | P value | ||
|---|---|---|---|
| Hospitalized N = 66 |
Non-hospitalized N = 383 |
||
| Age | |||
| Average±standard deviation(month) | 11.7 ± 10.2 | 15.5 ± 10.0 | 0.40 |
| < 6 months | 27 (30.3%) | 62 (69.7%) | |
| ≥ 6 months | 38 (10.7%) | 317 (89.3%) | <0.001 |
| Sex | |||
| Male | 43 (18.3%) | 192 (81.7%) | |
| Female | 23 (11.7%) | 173 (88.3%) | 0.08 |
| Prematurity and/or low birth weight a | |||
| Yes | 13 (34.2%) | 25 (65.8%) | |
| No | 53 (12.9%) | 358 (87.1%) | <0.001 |
| Underlying conditions b | |||
| Yes | 13 (61.9%) | 8 (38.1%) | |
| No | 53 (12.4%) | 375 (87.6%) | <0.001 |
| Genotype | |||
| NA1 | 16 (6.6%) | 227 (93.4%) | |
| ON1 | 42 (35.6%) | 76 (64.4%) | |
| BA9 | 7 (11.5%) | 54 (88.5%) | |
| BA10 | 1 (3.7%) | 26 (96.3%) | <0.001 |
Missing data exists in some categories.
a Prematurity was defined as gestation week <36 weeks, and low birth weight was <2500g.
b Underlying condition includes congenital heart diseases, congenital chronic lung diseases, immune deficiencies, Down Syndrome, or asthma.